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Electrophysiology and Ablation
AF is the most common sustained cardiac rhythm disorder and is 
associated with increased morbidity and mortality. Since the first 
description of AF initiation by triggers from pulmonary veins sleeves, 
pulmonary vein isolation (PVI) has become the standard ablation 
strategy in patients with AF.1 However, freedom from the arrhythmia, 
particularly in non-paroxysmal AF, remains suboptimal, and it is now 
clear that, in these patients, AF is maintained by an atrial substrate 
beyond the pulmonary veins. Although electrical remodelling may be 
reversible with termination of the arrhythmia, the development of atrial 
substrate due to fibrosis contributes to the progression of the AF 
phenotype from paroxysmal to persistent AF, leading to an arrhythmia 
that is more refractory to intervention.2 It is clear from animal and 
human studies that prolonged AF can cause this structural change. 
Moreover, it is also apparent that a range of risk factors associated with 
AF, including age, obesity, heart failure (HF), valvular heart disease, 
hypertension (HT), sleep apnoea and alcohol intake, may also progress 
atrial remodelling. The rise in the prevalence of cardiovascular risk 
factors (particularly driven by ageing populations and the obesity 
epidemic) has been associated with an increase in the prevalence of AF 
and AF-related hospitalisations.3 In this review, we focus on insights 
from electrophysiological mapping studies in cohorts with AF risk 
factors. We discuss substrate mapping and its implications for AF 
management and outcomes, and also focus on potential pitfalls.
The Second Factor: Structural Remodelling 
is Required for AF Maintenance
Early studies of animal models have demonstrated that AF promotes 
acute electrical remodelling, which in turn leads to further AF, thereby 
introducing the seminal concept that ‘AF begets AF’.4–6 In response 
to either induced AF or rapid atrial pacing, a reduction in the atrial 
effective refractory period (ERP) occurs with an increase in the spatial 
heterogeneity of ERP and loss of normal ERP rate adaptation, all 
resulting in progressively longer durations of AF. In this model, 
termination of the arrhythmia results in remodelling reversal, suggesting 
that sinus rhythm may beget sinus rhythm. However, human studies of 
early intervention to re-establish sinus rhythm do not fully support this 
concept; the re-establishment of sinus rhythm has not been found to 
prevent the progression of AF in the majority of patients.7,8 Ongoing 
work has indicated that, beyond acute electrical remodelling, structural 
remodelling also occurs and is not necessarily fully reversible. This so-
called second factor has been shown to occur as a result of longer 
durations of AF. However, the multiple conditions associated with AF 
also appear to promote significant structural remodelling.
Abnormal Atrial Substrates and Structural 
Remodelling in Conditions Predisposing to AF
It is well known that certain cardiac conditions and risk factors (i.e. age, 
obesity, HT, HF, structural heart disease, sleep apnoea and alcohol 
intake) are associated with AF, likely through both different and 
interacting mechanisms. In the next section, we review the evidence 
describing the nature of atrial structural remodelling in these conditions, 
even prior to the development of AF (Figure 1). 
The Role of Atrial Stretch
The impact of acute atrial stretch on electrical remodelling has 
been studied in animal models and in humans. Despite variability in 
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the reported effect on atrial ERP, evidence from these studies 
consistently demonstrates conduction slowing, conduction block and 
increased frequency of AF.9–11 In studies of atrial stretch related to loss 
of atrioventricular (AV) synchrony, Sparks et al. demonstrated evidence 
of both electrical and mechanical remodelling.12,13 Although 
refractoriness showed a variable increase, there was conduction 
slowing, sinus node impairment and a decrease in parameters of atrial 
contractile function. These changes developed over 3 months and were 
fully reversible with the return of AV synchrony.
Valvular and Congenital Heart Disease
The nature of atrial remodelling due to pressure and volume overload 
associated with either valvular heart disease or congenital heart 
defects has been studied for a number of different pathologies. 
Common to these is the development of significant atrial dilatation, 
creating one of the critical determinants for the maintenance of AF and 
structural remodelling.
In mitral stenosis, John et al. demonstrated the presence of abnormal 
atrial structural and electrical substrate in patients with symptomatic 
mitral stenosis referred for balloon valvuloplasty when compared to a 
control cohort.14 Biatrial mapping demonstrated significantly reduced 
biatrial voltage, reduced conduction velocity and prolonged ERPs. As 
expected, patients with mitral stenosis were more susceptible to AF 
induction with programmed extra stimuli. Such remodelling was found to 
be more profound in the left atrium (LA) than the right atrium (RA). Balloon 
valvuloplasty resulted in significant improvements in conduction and in 
bipolar voltage, either acutely or by 3 months of follow-up, indicating that 
even chronic remodelling may be, in part, reversible.15
Roberts-Thompson et al. studied patients with symptomatic mitral 
regurgitation referred for valve repair using epicardial plaque mapping 
in the operating room.16 Their high-density mapping study demonstrated 
the presence of conduction slowing, conduction heterogeneity with 
regions of conduction slowing and lines of block particularly in the 
posterior left atrium. Patients with mitral regurgitation had more 
advanced remodelling than a comparison group with normal mitral 
valves undergoing coronary bypass surgery. 
Morton et al. performed right atrial mapping in patients with atrial 
septal defect (ASD) before and late after surgical closure.17 
Electroanatomic maps of the RA demonstrated the presence of atrial 
conduction abnormalities, both generally and at the crista terminalis, 
sinus node dysfunction and atrial dilation, when compared to controls. 
In their study, closure of the ASD, while associated with significant 
reduction in atrial size, did not lead to recovery of conduction 
abnormalities, indicating partial reverse remodelling in this population. 
In a subsequent study, Roberts-Thomson et al. demonstrated similar 
atrial remodelling in the LA of ASD patients, indicating that the 
remodelling process is not confined to the RA in an ASD population.18
Congestive Heart Failure
The interaction between HF and AF has been studied in both animals 
and humans. Li et al. described remodelling ‘of a different sort’ in a 


















Electroanatomical maps from various AF substrates are shown with bipolar voltage scaled from red for <0.05 mV to purple for > 5mV (except alcohol maps, which are scaled from <0.05 to 
>0.5 mV). Points with fractionated or double potentials or scar are annotated with red, blue and grey dots, respectively. n/a=not available. Sources: Kistler et al. 2004,38 Dimitri et al. 2012,33 
Stiles et al. 2009,41 Mahajan et al. 201830 and Voskoboinik et al. 2019.36 Adapted with permission from Elsevier. Medi et al. 2011.25 Adapted with permission from Wiley. Sanders et al. 2003.22 
Adapted with permission from Wolters Kluwer. John et al. 2008.14 Adapted with permission from Oxford University Press. 
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canine model of ventricular tachypacing.19 This was characterised by 
an increase in conduction heterogeneity associated with interstitial 
fibrosis that resulted in an increase in AF inducibility. Other studies 
have demonstrated similar findings.20 Five weeks after HF reversal, 
neither fibrosis nor AF inducibility were found to demonstrate 
significant resolution.21
Sanders et al. demonstrated slowing of atrial conduction, low-voltage 
areas (LVAs), a greater number of fractionated electrograms and abnormal 
sinus node function in patients with congestive HF (CHF) when compared 
to a control population.22 Patients with CHF demonstrated increased AF 
inducibility. More recently, Prahbu et al. performed high-density 
electroanatomic mapping of both atria in two cohorts of patients: 
persistent AF with normal left ventricular systolic function (left ventricular 
ejection fraction [LVEF] >55%) and persistent AF with idiopathic 
cardiomyopathy (LVEF <45%).23 HF was associated with significantly 
reduced biatrial bipolar tissue voltages, greater voltage heterogeneity and 
significantly more biatrial electrogram fractionation compared to no HF, 
suggesting the impact of HF on structural remodelling above and beyond 
the effect of AF itself. When patients were restudied 2 years after catheter 
ablation with maintenance of sinus rhythm and significant improvement 
or normalisation of LV function, remodelling reversal was found to be 
incomplete.24 There was a reduction in complex signals and patchy 
regional increases in voltage, but no improvement in atrial conduction, 
again indicating that advanced remodelling is unlikely to reverse (Figure 2).
Systemic Hypertension
Medi et al. performed RA electroanatomic mapping in patients with HT 
(but no AF) and in controls.25 HT was associated with extensive 
conduction abnormalities, particularly in the posterior RA at the crista 
terminalis. In addition, an increased number of LVAs and AF inducibility 
were noted, despite prolonged ERPs compared to controls. To the best 
of our knowledge, no studies have evaluated the impact of HT on LA 
remodelling; however, studies in patients with HF and preserved 
ejection fraction are ongoing.
Obesity
Emerging data have indicated that obesity and increased pericardial fat 
are associated with a more advanced atrial substrate. A number of 
animal studies have demonstrated the impact of progressive weight 
gain on the atrial substrate and inducibility of AF.26,27 Abed et al. 
demonstrated the progressive change in electrical and structural 
remodelling in a group of 30 sheep fed a high-calorie diet over an 
8-month period.26 Increasing weight was associated with increasing LA 
volume, fibrosis, upregulation of inflammatory markers, decreased 
conduction velocity and an increase in conduction heterogeneity. Such 
changes were found to be associated with an increase in both inducible 
and spontaneous AF. In a subsequent study, the same group 
demonstrated that these changes were most marked in the posterior 
left atrium and were associated with fat infiltration and fibrosis. Other 
animal studies noted that a high-fat diet could increase AF duration due 
to slow atrial conduction and reduced pulmonary vein refractoriness 
without necessarily accompanying obesity.28,29 Mahajan et al. compared 
atrial electroanatomic maps and epicardial adipose tissue in obese 
patients with the same data from a non-obese cohort.30 Obesity was 
found to be associated with an increase in all measures of epicardial 
adipose tissue (EAT), with a predominant distribution adjacent to the 
posterior left atrium and the atrioventricular groove. Obese patients 
had reduced global conduction velocity, increased fractionation and 
increased LVAs. LVAs were predominantly seen in the posterior and/or 
inferior LA, matching the location of EAT on cardiac magnetic resonance 
(CMR) imaging. Another study of the impact of obesity on atrial 
remodelling also found significant conduction slowing at the pulmonary 
vein-to-LA junction.31
Obstructive Sleep Apnoea
Obstructive sleep apnoea (OSA) is known to be associated with AF.32 
Dimitri et al. characterised the atrial substrate among a cohort of 
patients undergoing AF ablation who either had OSA (apnoea hypopnea 
index >15) or no OSA.33 Patients with OSA had lower atrial voltage, 
prolonged conduction times and greater percentage of complex 
fractionated electrograms, but there was no difference in atrial ERP. 
Similar findings were recently described by Anter et al. in their cohort 
of 86 patients (n=43 with OSA and n=43 without OSA) undergoing PVI 
for paroxysmal AF.34 However, they also reported a higher prevalence of 
non-pulmonary vein triggers in OSA compared to controls, indicating 
that the development of AF in this population may be due to 
autonomically mediated triggers interacting with chronic substrate.
Alcohol
Alcohol has recently emerged as an important modifiable risk factor in 
AF, and both binge and habitual drinking seem to increase the 
vulnerability to AF through its impact on atrial remodelling. Qiao et al. 
performed voltage mapping in 122 patients undergoing PVI for 
paroxysmal AF, and classified them according to their daily alcohol 
consumption history.35 Heavy drinkers had more LVAs and more AF 
recurrences compared to moderate drinkers and alcohol abstainers. 
Importantly, both heavy alcohol consumption and LVAs were 
independent predictors of AF recurrence. Similar findings were recently 
found in Voskoboinik et al.’s study of the atrial substrate among alcohol 
consumers.36 The authors performed high-density electroanatomic 
mapping of the LA in 75 patients undergoing PVI for AF. Patients were 
classified as lifelong non-drinkers, mild drinkers (2–7 drinks/week) and 
Figure 2: Electroanatomic Maps of the Right Atrium at 
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Right Atrial Electro-Anatomical map
Baseline and follow-up bipolar voltage maps of the RA demonstrating an increase in bipolar 
voltage and a decrease in fractionation in the posterior-septal segment(s). A,B: Posterior–
anterior projection with lateral rotation at baseline; C,D: the same view at follow-up. A,C: 
Unadjusted automatic bipolar voltage. B,D: Bipolar voltage maps adjusted to 0 to 0.5 to 1.0 
mV. Low voltage is represented by red. Fractionated signals are marked with a turquoise 
arrow and circle. IVC=inferior vena cave; SVC=superior vena cava. Source: Sugumar et al. 
2019.24 Reproduced with permission from Elsevier.
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moderate drinkers (8–21 drinks/week). When compared to alcohol 
abstinence or mild alcohol consumption, moderate alcohol 
consumption was associated with significantly lower global atrial 
voltage, slower conduction velocities and an increased proportion of 
both complex atrial potentials and LVAs. Moderate drinking, together 
with age and female sex, were found to be independent predictors for 
low voltage. Ongoing studies are addressing the question of whether 
atrial remodelling may reverse with abstinence, and a recent 
randomised study indicated that abstinence reduces AF recurrence.37
Age
It is well known that the prevalence of AF increases with age. A number 
of animal and human studies have demonstrated the presence of an 
abnormal electrical substrate in older cohorts, independent of changes 
in the atrial ERP.38–40 Kistler et al. performed high-density electroanatomic 
mapping of the RA in 41 patients with no history of AF.38 Patients were 
stratified into three groups according to age: <30 years, 30–60 years 
and >60 years. Ageing was associated with regional conduction 
slowing, anatomically determined conduction delay at the crista 
terminalis, areas of low voltage, impaired sinus node function, and an 
increase in atrial ERP.
Lone AF and Fibrotic Cardiomyopathy
The term ‘lone AF’ has been variably defined over decades of use, but 
broadly, can be taken to imply AF in the absence of structural heart 
disease or HT. In a detailed mapping study, Stiles et al. demonstrated 
the presence of abnormal atrial substrate in patients with paroxysmal 
lone AF compared to a control group, even when studied distant to an 
AF episode.41 Paroxysmal AF patients were found to have atrial 
dilatation, lower mean voltage, prolonged atrial conduction times, 
impaired sinus node function and increased atrial ERP compared to the 
control group. However, in their study, more contemporary causes of 
atrial remodelling, such as obesity, sleep apnoea and alcohol intake, 
were not clearly excluded, and it is possible that the observed 
remodelling reflected the high prevalence of these conditions in an 
apparent lone AF population. An alternate hypothesis is that AF is 
secondary to a primary underlying fibrotic cardiomyopathy, as proposed 
by Kottkamp et al.42 Human histological and imaging studies evaluating 
fibrosis in lone and non-lone AF populations have found comparable 
fibrosis distribution between the two groups,43,44 supporting the idea of 
a primary fibrotic cardiomyopathy. However, a detailed exclusion of the 
above causes of remodelling was not performed.
How Best to Define Abnormal Atrial 
Substrate: Pitfalls
On electroanatomic mapping, the assumption inherent in the findings 
of low voltage, slowed conduction and complex signals is that structural 
change is present, the hallmark of which is fibrosis.45 Human histological 
studies have confirmed the presence of atrial fibrosis in patients with 
AF, and the fibrosis extent correlated with AF duration.43,46,47
However, to date, there is no direct correlation confirming the relationship 
between atrial substrate on mapping and histological fibrosis. The widely 
applied definition of abnormal atrial bipolar voltage (<0.5 mV representing 
LVAs and <0.05 mV representing scar) derives from mapping with an 
ablation catheter bipole and has never been fully validated in humans.22 
The indices have been used to successfully predict outcomes when used 
to define LVA in patients with paroxysmal or persistent AF.48–50 Furthermore, 
complex fractionated electrograms and abnormal conduction during 
sinus rhythm tend to correspond to LVAs, suggesting that they may 
represent areas of histological fibrosis.51,52 However, multiple potential 
pitfalls exist when simply using voltage as a marker of atrial remodelling 
and fibrosis. For example, atrial wall thickness varies markedly between 
different atrial regions (e.g. trabeculated compared with smooth-walled 
atrium), and also from patient to patient. It is highly probable that normal 
voltage also varies considerably and may defy a simple cut-point 
definition. Moreover, these values were described when using an ablation 
bipole for mapping. The start of the century has witnessed the introduction 
of multielectrode mapping catheters for electroanatomic mapping.53 
Compared with linear, single-point conventional mapping catheters, 
multielectrode mapping catheters have the combination of smaller 
electrode size, smaller interelectrode distance and multiple splines. This 
allows for recording electrograms from a significantly smaller underlying 
tissue diameter with multiple orientations. This translates to higher 
mapping resolution that can identify heterogeneity within the area of low 
voltage, localising channels of surviving bundles. Moreover, the smaller 
electrode and closer interelectrode spacing means less signal averages 
and cancellation effects, which may translate to higher recorded bipolar 
voltage amplitude with shorter electrogram duration.53,54 However, the 
criteria for bipolar low voltage using multielectrode mapping catheters 
has not been systematically revisited. 
It is also important to note that both the distribution and extent of LVAs 
on electroanatomic mapping is critically dependent on the directionally 
and rate of wavefront prorogation. Wong et al. demonstrated that a 
change in pacing site or cycle length could change the region defined 
as low voltage by up to 30% (Figure 3).55
The nature of the rhythm is also of critical importance. Several early 
studies demonstrated that regions of low bipolar voltage and complex 
fractionated electrograms recorded during AF frequently correspond 
with areas of normal atrial bipolar voltages in sinus rhythm.52,56 
However, recent studies using omnipolar mapping, indicating that 
electrode orientation is a key determinant of recorded bipolar voltage, 
Figure 3: Rate- and Direction-dependent 
Variation in Mapped Substrate
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Patient 2 Patient 3
PAPA AP
Electroanatomic maps demonstrating significant progressive increase in low-voltage areas 
(LVAs; <0.5 mV) typically targeted in adjective scar homogenisation ablation strategies 
according to different pacing methods in three different patients (area in red). Complex 
fractionated electrograms from corresponding regions in patient 3 (right side, a 72-year-old 
man with early persistent AF) are longer, with lower voltages in response to each subsequent 
pacing strategy. Impact of pacing cycle length and wavefront direction in the potential atrial 
area included in substrate ablation is highlight. AP= anteroposterior; CSD = distal coronary 
sinus; LSPV = left superior pulmonary vein; PA = posteroanterior. Source: Wong et al. 2019.55 
Reproduced with permission from Elsevier.
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have raised the possibility that mapping during AF may provide an 
improved evaluation of underlying substrate. In an elegant study using 
omnipolar mapping with a grid catheter, Haldar et al. showed that 
bipole orientation has a significant impact on bipolar electrogram 
(EGM) voltages obtained during sinus rhythm (SR) and AF.57 In that study, 
omnipolar EGMs were able to extract maximal voltages from AF signals 
not influenced by directional factors, wavefront collision or fractionation. 
Other techniques to identify substrate have focused on signal 
characteristics. Approaches beyond the traditional identification of 
complex fractionated electrograms have included targeting spatio-
temporal dispersion of electrograms; targeting regions of prolonged 
and continuous fractionation; various approaches to determine the site 
of highest activation frequency, such as dominant frequency; or using 
activation gradients, such as in the stochastic trajectory analysis of 
ranked signals mapping approach.58–61
In addition to mapping techniques, multimodality imaging can provide 
a non-invasive assessment of the abnormal atrial substrate in patients 
with AF.62 In addition to atrial size and morphology, mechanical and 
structural remodelling parameters can be obtained via strain imaging 
and late gadolinium enhancement CMR imaging (LGE-MRI). LGE-MRI 
has been proposed as a more effective way in which to identify regions 
of atrial fibrosis, and a considerable body of work indicates that this 
may be feasible. However, not many departments have been able to 
replicate these data, particularly for the reliable identification of more 
subtle interstitial fibrosis.62 A key problem is how to accurately define 
the number of standard deviations (SD) from the mean reference signal 
intensity, which most closely describes accurate scar volume. In an 
animal ablation study, the point at which CMR imaging and histological 
scar volume were equal was in the steepest portion of the graph, which 
meant any small change in SD (chosen by definition) would create a 
corresponding large difference between CMR imaging and histological 
measured volumes.63 Chen et al. studied the correlation between 
delayed enhancement on CMR imaging and LVAs on electroanatomic 
mapping in 16 patients with persistent AF.64 There was a mismatch 
between delayed enhancement areas and LVAs; delayed enhancement 
was present in 61% of LVAs, whereas low voltage was present in 28% of 
delayed enhancement areas. In another recent multimodal examination 
of AF substrate, Zghaib et al. demonstrated that LGE-MRI, high-density 
mapping and point-by-point mapping with the ablation catheter 
demonstrated good correlation in delineating electroanatomical AF 
substrate, providing some enthusiasm for the routine use of CMR 
imaging.65 Given the current challenges in technique and reproducibility, 
and the lack of prospective studies, the current role for LGE-MRI in the 
management of patients with non-paroxysmal AF remains limited to a 
relatively small number of centres with extensive experience in the 
technique. Data from the prospective Delayed-Enhancement MRI 
Determinant of Successful Radiofrequency Catheter Ablation of Atrial 
Fibrillation-II (DECAAF-II) study are eagerly awaited.62
Implications of Accurately Identifying 
the Atrial Substrate
Numerous studies have indicated that advanced atrial substrate is a 
risk factor for recurrence following AF ablation.48,49,66,67 In addition, 
preliminary and observational studies suggest that isolation or 
homogenisation of these abnormal regions significantly improves post-
ablation arrhythmia-free survival.59,69,70 Schreiber et al. implemented 
the concept box isolation of fibrotic areas and studied its impact when 
added to traditional PVI on AF-free survival among 92 patients with 
fibrotic atrial cardiomyopathy, as defined by voltage mapping.71 This 
approach was associated with a 69% arrhythmia-free survival at 16 ± 8 
months. In a single-centre randomised study, Kircher et al. examined 
whether targeting LVAs in addition to PVI was more effective than PVI 
plus linear ablation in patients with paroxysmal and persistent AF.72 At 
Figure 4: Recurrence of AF 13 Years Following Successful Pulmonary Vein Isolation
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Middle-aged man with a history of permanent pacemaker insertion in 2004 for sick sinus syndrome. He underwent circumferential pulmonary vein isolation in July 2005 for symptomatic 
high-burden AF. He remained AF free over the following 13 years, but gained 12 kg, developed hypertension and moderate obstructive sleep apnoea during that period. Recurrence of 
symptomatic high-burden AF in February 2018 was documented. Redo procedure demonstrated enduring isolation in all four pulmonary veins; however, repetitive atrial ectopic activity 
initiating AF in the posterior wall (PW) was noted. Following isolation of the PW, the patient remained arrhythmia free over a 12-month period. ABL = ablation catheter; CPVI = circumferential 
pulmonary vein isolation; CSd = distal coronary sinus; CSp = proximal coronary sinus; HBE = His bundle electrogram; LA = left atrium.
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12 months, the LVA ablation group had better arrhythmia-free survival 
compared to the PVI plus linear ablation group (68% versus 42%, 
p=0.003). More recently, Yang et al. randomised 229 patients with non-
paroxysmal AF to either low-voltage, zone-guided ablation or standard 
stepwise ablation (including linear ablation), but did not show a 
significant improvement in arrhythmia-free survival at 18 months (74% 
versus 71%, p=0.32).73 However, procedure times, total ablation time 
and fluoroscopy times were significant shorter using the LVA-guided 
approach. Further multicentre studies are needed to better define the 
role of LVA-guided substrate ablation in the management of patients 
with persistent AF. A prospective multicentre randomised study is 
currently ongoing to examine the efficacy of atrial fibrosis (based on 
MRI-LGE)-guided ablation intervention in the treatment of patients with 
persistent AF (DECAAF-II, NCT02529319).
Progression and Regression of 
the Atrial Substrate
In many patients with AF, there is gradual progression from short-
lasting paroxysmal AF to more frequent and persistent AF (Figure 4).74,75 
This progression is, at least in part, driven by the evolution of the atrial 
substrate as a result of underlying risk factors and the arrhythmia itself. 
As such, the hypothesis emerged that both risk factor management 
and rhythm control might arrest the progression and perhaps reverse 
the remodelling of the atrial substrate in AF (Figure 5).76,77 The data are 
mixed. Animal studies of structural remodelling reversal have shown 
variable results, but established replacement fibrosis has not resolved.78 
In humans, AF ablation did not result in reverse remodelling at 6 
months, with some evidence of further progression.79 Studies of risk 
factor management have indicated a significant propensity for reverse 
remodelling in animal studies. In humans, risk factor management has 
resulted in fewer recurrences of AF after ablation, and reversal of AF 
progression.37,76,80 Patients with weight loss frequently regress from a 
persistent to paroxysmal phenotype and progress in the opposite 
direction much less frequently.82
Conclusion
The abnormal atrial substrate plays a key role in the perpetuation of AF. 
While developing an ablation strategy targeting the atrial substrate 
seems logical, the current mixed results may reflect uncertainties as to 
how best to identify the critical arrhythmogenic substrate. Future 
improvements in mapping and imaging technology will certainly 
improve our understanding of the atrial substrate, and potentially pave 
the way for the development of tailored ablation therapies to improve 
arrhythmia outcomes. 
Figure 5: Time-dependent Atrial Remodelling 














Progression of AF risk factors
Hypothetic construct over time indicating the interrelationship between time, risk factors 
for AF, atrial remodelling, detection of risk factors for atrial remodelling and progression 
from sinus rhythm through paroxysmal and persistent to permanent AF. ECV = electrical 
cardioversion; SR = sinus rhythm. Source: Wyse et al. 2014.81 Reproduced with permission 
from Elsevier.
Clinical Perspective
• Structural remodelling plays an important role in the development 
and clinical progression of AF.
• Beyond the impact of AF itself on structural remodelling, multiple 
associated conditions contribute to the development of 
abnormal atrial substrate.
• Further improvements in current atrial substrate imaging and 
mapping modalities are required to improve our understanding 
of structural remodelling to better guide substrate-based 
ablation strategies.
• Promising emerging work suggests an important role for risk 
factor management in arresting or reversing atrial remodelling 
and in improving AF outcomes. Further work is required to 
define the broader efficacy of this approach.
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